Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001193125-04-028659
Filing Date
2004-02-24
Accepted
2004-02-24 16:02:36
Documents
8
Period of Report
2003-12-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-K d10k.htm 10-K 994385
3 LETTER AMENDMENT TO LICENSE, RESEARCH & DEVELOPMENT AGREEMENT dex1033.htm EX-10.33 14787
4 COMPUTATION OF RATIO OF EARNINGS TO FIXED CHARGES dex12a.htm EX-12.A 6853
5 CONSENT OF KPMG LLP dex23.htm EX-23 2305
6 CERTIFICATION OF CEO PURSUANT TO SS 302 dex311.htm EX-31.1 7086
7 CERTIFICATION OF CFO PURSUANT TO SS 302 dex312.htm EX-31.2 7229
8 CERTIFICATION OF CEO PURSUANT TO SS 906 dex321.htm EX-32.1 3315
9 CERTIFICATION OF CFO PURSUANT TO SS 906 dex322.htm EX-32.2 3327
  Complete submission text file 0001193125-04-028659.txt   1041876
Mailing Address 5775 WEST OLD SHAKOPEE RD SUITE 100 MINNEAPOLIS MN 55437
Business Address 5775 WEST OLD SHAKOPEE RD SUITE 100 BLOOMINGTON MN 55437 952-346-4700
MGI PHARMA INC (Filer) CIK: 0000702131 (see all company filings)

EIN.: 411364647 | State of Incorp.: MN | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 000-10736 | Film No.: 04625014
SIC: 2834 Pharmaceutical Preparations